Renal Failure, 0886-022X

Journal

  1. 2016
  2. 2015
  3. Meulendijks, F. G., Hamaker, M. E., Boereboom, F. T. J., Kalf, A., Vogtlander, N. P. J., & van Munster, B. C. (2015). Groningen frailty indicator in older patients with end-stage renal disease. Renal Failure, 37(9), 1419-1424. https://doi.org/10.3109/0886022X.2015.1077315
  4. 2001
  5. Haverdings, RFG., Haas, M., Greupink, AR., de Vries, PAM., Moolenaar, F., de Zeeuw, D., & Meijer, DKF. (2001). Potentials and limitations of the low-molecular-weight protein lysozyme as a carrier for renal drug targeting. Renal Failure, 23(3-4), 397-409.
  6. 1998
  7. Kok, R. J., Haas, M., Moolenaar, F., de Zeeuw, D., & Meijer, D. K. F. (1998). Drug delivery to the kidneys and bladder with the low molecular weight protein lysozyme. Renal Failure, 2, 211 - 217.

ID: 770833